Tracon Pharmaceuticals Inc., a San Diego-based oncology drug company, has raised $9.5 million in senior convertible note financing, according to a regulatory filing. The deal was placed by Tracon backer Paramount Biosciences. www.traconpharma.com
Tracon Pharmaceuticals Inc., a San Diego-based oncology drug company, has raised $9.5 million in senior convertible note financing, according to a regulatory filing. The deal was placed by Tracon backer Paramount Biosciences. www.traconpharma.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
